AAAAAA
Results:
1-22
|
Results: 22
Authors:
GHALI WA
QUAN H
BRANT R
Citation: Wa. Ghali et al., CORONARY-ARTERY BYPASS-GRAFTING IN CANADA - HOSPITAL MORTALITY-RATES,1992-1995, CMAJ. Canadian Medical Association journal, 159(8), 1998, pp. 926-930
Authors:
GHALI WA
QUAN H
BRANT R
Citation: Wa. Ghali et al., CORONARY-ARTERY BYPASS-GRAFTING IN CANADA - NATIONAL AND PROVINCIAL MORTALITY TRENDS, 1992-1995, CMAJ. Canadian Medical Association journal, 159(1), 1998, pp. 25-31
Authors:
SHIH WJ
QUAN H
Citation: Wj. Shih et H. Quan, TESTING FOR TREATMENT DIFFERENCES WITH DROPOUTS PRESENT IN CLINICAL-TRIALS - A COMPOSITE APPROACH BY SHIH,WEICHUNG,J. AND QUAN,HUI, STATISTICS IN MEDICINE, 16, 1225-1239 (1997) - REPLY, Statistics in medicine, 17(9), 1998, pp. 1063-1064
Authors:
GHALI WA
QUAN H
MORRIS CM
BRANT R
KNUDTSON ML
Citation: Wa. Ghali et al., PLOTTING ADJUSTED SURVIVAL CURVES FROM PROPORTIONAL HAZARDS MODELS - A COMPARISON OF 2 METHODS, Medical decision making, 18(4), 1998, pp. 490-490
Authors:
QUAN H
BOLOGNESE J
LONG JM
YUAN WY
Citation: H. Quan et al., ASSESSMENT OF EQUIVALENCE ON MULTIPLE END-POINTS, Zhongguo yaoli xuebao, 19, 1998, pp. 27-28
Authors:
SHIH WJ
QUAN H
Citation: Wj. Shih et H. Quan, STRATIFIED TESTING FOR TREATMENT EFFECTS WITH MISSING DATA, Biometrics, 54(2), 1998, pp. 782-787
Authors:
REN JZ
DING ZL
LIU DS
QUAN H
Citation: Jz. Ren et al., CLIMATIC INSTABILITY RECORD DURING THE PENULTIMATE GLACIATION - EVIDENCE FROM HUINING LOESS, Chinese Science Bulletin, 42(20), 1997, pp. 1720-1723
Authors:
SHIH WJ
QUAN H
Citation: Wj. Shih et H. Quan, TESTING FOR TREATMENT DIFFERENCES WITH DROPOUTS PRESENT IN CLINICAL-TRIALS - A COMPOSITE APPROACH, Statistics in medicine, 16(11), 1997, pp. 1225-1239
Authors:
SONG JL
QUAN H
WANG CC
Citation: Jl. Song et al., DEPENDENCE OF THE ANTI-CHAPERONE ACTIVITY OF PROTEIN DISULFIDE-ISOMERASE ON ITS CHAPERONE ACTIVITY, Biochemical journal, 328, 1997, pp. 841-846
Authors:
ZHANG J
QUAN H
NG J
STEPANAVAGE ME
Citation: J. Zhang et al., SOME STATISTICAL-METHODS FOR MULTIPLE END-POINTS IN CLINICAL-TRIALS, Controlled clinical trials, 18(3), 1997, pp. 204-221
Authors:
GAO Y
QUAN H
JIANG MY
DAI Y
WANG CC
Citation: Y. Gao et al., MUTANT HUMAN PROTEIN DISULFIDE-ISOMERASE ASSISTS PROTEIN-FOLDING IN ACHAPERONE-LIKE FASHION, Journal of biotechnology, 54(2), 1997, pp. 105-112
Authors:
LANZA F
SIMON T
QUAN H
BOLOGNESE J
RACK MF
HOOVER M
WILSON F
Citation: F. Lanza et al., SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2 (COX-2) WITH MK-0966 (250 MGQD) IS ASSOCIATED WITH LESS GASTRODUODENAL DAMAGE THAN ASPIRIN (ASA) 650 MG QID OR IBUPROFEN (IBU) 800 MG TID, Gastroenterology, 112(4), 1997, pp. 194-194
Authors:
ZHENG WD
QUAN H
SONG JL
YANG SL
WANG CC
Citation: Wd. Zheng et al., DOES DSBA HAVE CHAPERONE-LIKE ACTIVITY, Archives of biochemistry and biophysics, 337(2), 1997, pp. 326-331
Authors:
APPELMELK BJ
SIMOONSSMIT I
NEGRINI R
MORAN AP
ASPINALL GO
FORTE JG
DEVRIES T
QUAN H
VERBOOM T
MAASKANT JJ
GHIARA P
KUIPERS EJ
BLOEMENA E
TADEMA TM
TOWNSEND RR
TYAGARAJAN K
CROTHERS JM
MONTEIRO MA
SAVIO A
DEGRAAFF J
Citation: Bj. Appelmelk et al., POTENTIAL ROLE OF MOLECULAR MIMICRY BETWEEN HELICOBACTER-PYLORI LIPOPOLYSACCHARIDE AND HOST LEWIS BLOOD-GROUP ANTIGENS IN AUTOIMMUNITY, Infection and immunity, 64(6), 1996, pp. 2031-2040
Authors:
QUAN H
SHIH WJ
Citation: H. Quan et Wj. Shih, ASSESSING REPRODUCIBILITY BY THE WITHIN-SUBJECT COEFFICIENT OF VARIATION WITH RANDOM EFFECTS MODELS, Biometrics, 52(4), 1996, pp. 1195-1203
Authors:
LIBERMAN UA
WEISS SR
BROLL J
MINNE HW
QUAN H
BELL NH
RODRIGUEZPORTALES J
DOWNS RW
DEQUEKER J
FAVUS M
SEEMAN E
RECKER RR
CAPIZZI T
SANTORA AC
LOMBARDI A
SHAH RV
HIRSCH LJ
KARPF DB
Citation: Ua. Liberman et al., EFFECT OF ORAL ALENDRONATE ON BONE-MINERAL DENSITY AND THE INCIDENCE OF FRACTURES IN POSTMENOPAUSAL OSTEOPOROSIS, The New England journal of medicine, 333(22), 1995, pp. 1437-1443
Authors:
QUAN H
FAN GB
WANG CC
Citation: H. Quan et al., INDEPENDENCE OF THE CHAPERONE ACTIVITY OF PROTEIN DISULFIDE-ISOMERASEFROM ITS THIOREDOXIN-LIKE ACTIVE-SITE, The Journal of biological chemistry, 270(29), 1995, pp. 17078-17080
Authors:
GERTZ BJ
HOLLAND SH
KLINE WF
MATUSZEWSKI BK
FREEMAN A
QUAN H
LASSETER KC
MUCKLOW JC
PORRAS AG
Citation: Bj. Gertz et al., STUDIES OF THE ORAL BIOAVAILABILITY OF ALENDRONATE, Clinical pharmacology and therapeutics, 58(3), 1995, pp. 288-298
Authors:
BANKHURST A
MCILWAIN H
EMKEY R
YOOD R
ROMANOWICZ A
PASSERI M
QUAN H
SHAPIRO D
DAIFOTIS A
KARPF D
Citation: A. Bankhurst et al., 3-YEAR TREATMENT WITH ALENDRONATE PREVENTS FRACTURES IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS, Arthritis and rheumatism, 38(9), 1995, pp. 1238-1238
Authors:
GERTZ BJ
SHAO P
HANSON DA
QUAN H
HARRIS ST
GENANT HK
CHESNUT CH
EYRE DR
Citation: Bj. Gertz et al., MONITORING BONE-RESORPTION IN EARLY POSTMENOPAUSAL WOMEN BY AN IMMUNOASSAY FOR CROSS-LINKED COLLAGEN PEPTIDES IN URINE, Journal of bone and mineral research, 9(2), 1994, pp. 135-142
Authors:
CAMPBELL JW
DEACON A
HABASH J
HELLIWELL JR
MCSWEENEY S
QUAN H
RAFTERY J
SNELL E
Citation: Jw. Campbell et al., ELECTRON-DENSITY MAPS OF LYSOZYME CALCULATED USING SYNCHROTRON LAUE DATA COMPRISING SINGLES AND DECONVOLUTED MULTIPLES, Bulletin of Materials Science, 17(1), 1994, pp. 1-18
Authors:
LEE YJ
QUAN H
Citation: Yj. Lee et H. Quan, P-VALUES AFTER REPEATED SIGNIFICANCE TESTING - A SIMPLE APPROXIMATIONMETHOD, Statistics in medicine, 12(7), 1993, pp. 675-684
Risultati:
1-22
|